Agenda
Thursday, May 4th, 2017
7:30 - 8:00 AM
Breakfast Breakout Check-in & Networking Breakfast
Sponsored By:
8:00 - 8:45 AM
Breakfast Breakout Sessions
Dry Eye
Dry eye disease is one of the most common reasons for a patient visit to an eye care professional's office and impacts greatly on patient satisfaction and surgical outcomes. Diagnostic and treatment paradigms are changing rapidly. Recent advances and the upcoming pipeline in point of service testing and therapeutics will be discussed.
Moderator: Eric Donnenfeld, MD, Founding Partner - OCLI
Michael Ackermann, PhD, VP, Neurostimulation - Allergan
John Sheppard, MD, President - Virginia Eye Consultants
Glaucoma
Drug delivery in glaucoma and combining drug delivery with MIGs for the next generation therapy.
Moderator: Richard Lewis, MD, Founder - Sacramento Eye Consultants
Judy Gordon, Founder & President - ClinReg Consulting Services
Thomas Samuelson, MD, Founding Partner - Minnesota Eye Consultants
Michael Robinson, MD, VP & Therapeutic Area Head, Anterior Segment and Consumer Eye Care - Allergan
Presbyopia
Presbyopia correction continues to serve as the refractive Holy Grail in Ophthalmology. The session will review the scope of current disruptive technologies and their current market penetrance, discuss investigational therapies that are in the pipeline, and brainstorm on ways to collectively improve our patient outcomes with our current surgical options.
Moderator: Elizabeth Yeu, MD - Virginia Eye Consultants
Sarah Cannon, VP, Global Marketing - ReVision Optics
Yari Mitchell, VP, Global Medical Affairs & Business Strategy - AcuFocus
William Wiley, MD, Medical Director - Cleveland Eye Clinic
Refractive Correction
A review of the refractive market with an emphasis on the future and what companies can teach us about their commitment to grow the market. The session will look at new technologies entering the market such as topo guided, SMILE, low add multifocals, extended depth of focus implants.
Moderator: Vance Thompson, MD - Vance Thompson Vision
Laurent Attias, Head, Strategy, BD&L and M&A - Alcon
Terence Koritz, VP, Global Strategic Marketing, Surgical - Johnson & Johnson Vision
Dirk Muehlhoff, VP, Refractive Laser Business Unit - Carl Zeiss Meditec
Kerry Solomon, MD, Managing Partner - Carolina Eyecare Physicians
MIGS
The MIGS landscape is rapidly changing with new devices that recently entered the category. This session will discuss which technologies will be the best for different types of patients and the role future technologies can play in an ever-more competitive market.
Moderator: John Berdahl, MD - Vance Thompson Vision
Ron Bache, President & CEO - Bache, Inc.
Nathan Radcliffe, MD - NYU Langone Ophthalmology Associates
Paul Singh, MD - Eye Centers, Racine & Kenosha
FDA
FDA Update & Reimbursement Strategies.
Moderator: Richard Lindstrom, MD, Founder & Attending Surgeon - Minnesota Eye Consultants
Malvina Eydelman, MD, Director, Division of Ophthalmic and Ear, Nose & Throat Devices - FDA
Allison Shuren, Partner - Arnold & Porter Kaye Scholer
Kuldev Singh, MD, Professor of Ophthalmology - Stanford University
8:15 - 9:00 AM
General Attendance Check-in & Networking Breakfast
Sponsored By:
9:00 - 9:15 AM
Front of Mind, Front of Eye: Anterior Segment Innovation Update
Gilbert H. Kliman, MD, Managing Director - InterWest Partners
9:15 - 10:15 AM
Ophthalmology Innovation Showcase 1
9:15 – 9:21 | Aerie Pharmaceuticals | Tom Mitro, President & COO
9:21 – 9:27 | Ocular Therapeutix | Jonathan Talamo, MD, Chief Medical Officer
9:27 – 9:33 | Mati Therapeutics | Bob Butchofsky, CEO
9:33 – 9:39 | InnFocus (A Santen Company) | Russ Trenary, President & CEO
9:39 – 9:45 | Ivantis | Dave Van Meter, President & CEO
9:45 – 9:51 | EyeGate Pharma | Stephen From, CEO
9:51 – 9:57 | Cassini | Mark Packer, MD, Chief Medical Officer
9:57 – 10:03 | LacriScience | Chris Geddes, MD, Chief Biomedical/Plasmonics Consultant
10:03 – 10:09 | Kala Pharmaceuticals | Mark Iwicki, Chairman & CEO
10:09 – 10:15 | SightGlass Vision | Thomas Chalberg, Founder & CEO
10:15 - 10:39 AM
Morning Networking & Refreshment Break
Sponsored By:
10:39 - 11:45 AM
Ophthalmology Innovation Showcase 2
10:39 – 10:45 | Avedro | Reza Zadno, President & CEO
10:45 – 10:51 | ClarVista Medical | Paul McLean, CEO
10:51 – 10:57 | Omega Ophthalmics | Gary Wörtz, MD, Chief Medical Officer
10:57 – 11:03 | Mynosys Cellular Devices | John Hendrick, President & CEO
11:03 – 11:09 | PowerVision | Barry Cheskin, Co-Founder, President & CEO
11:09 – 11:15 | Refocus Group | Mike Judy, CEO
11:15 – 11:21 | AcuFocus | Yari Mitchell, VP, Global Medical Affairs & Business Strategy
11:21 – 11:27 | ReVision Optics | Sarah Cannon, VP, Global Marketing
11:27 – 11:33 | Presbia | Gerd Auffarth, MD, Board Member
11:33 – 11:39 | Presbyopia Therapies | Jim McCollum, Co-Founder & Board Member
11:39 – 11:45 | SightLife Surgical | Monty Montoya, President & CEO
11:45 - 11:48 AM
OIS Index: 2017 Update
We introduced the OIS Index, a composite of ophthalmic growth stocks, in October at OIS@AAO with the purpose of tracking the performance of our sector. The components of the OIS Index are publicly traded small- and mid-cap growth companies in ophthalmology that derive at least half of their value from ophthalmic products and technology. The index was launched with a base value of 1,000. The index is initially weighted about 70% biopharma and 30% ophthalmic device, based on both number of companies and company valuations. Company market caps range from $5 million to $3 billion, with a median of $170 million.
Michael Lachman, President - EyeQ Research
11:48 - 12:30 PM
Device Financing 2017
Public Markets Overview
Andrew Gitkin, Head, West Coast Biotechnology Investment Banking - Piper Jaffray
Private Funding Overview
Jonathan Norris, Managing Director - SVB
Panel Discussion
Moderated By:
Emmett T. Cunningham Jr., MD, PhD, MPH, Managing Director - Clarus Funds
Participants:
Juliet Tammenoms Bakker, Managing Director - Longitude Capital
Ali Behbahani, MD, Partner - NEA
Andy Corley, Principal - Yelroc Consulting
J.P. Peltier, Global Head Healthcare Investment Banking - Piper Jaffray
Wende Hutton, General Partner - Canaan Partners
Jonathan Norris, Managing Director - SVB
12:30 PM
Networking Lunch Commences
Sponsored By:
1:15 - 1:30 PM
OIS Innovator Award - Presented to Oculeve
Award Recipient:
Michael Ackermann, PhD, Former CEO - Oculeve/VP, Neurostimulation - Allergan
Presented By:
William J. Link, PhD, Managing Director - Versant Ventures
1:30 PM
Lunch Concludes
1:30 - 2:15 PM
Spotlight on Dry Eye
The Dry Eye session will feature updates from corporate leaders of the leading dry eye companies on their products in this field. In addition, clinical experts will discuss the most current as well as future strategies in the diagnosis and treatment of dry eye disease.
Market Overview
Edward Holland, MD, Director, Cornea Services - Cincinnati Eye Institute
Company Presentations
Allergan | Aziz Mottiwala, VP, Marketing
Shire | Amir Shojaei, PhD, VP, Global Development & Product Strategy Lead
Sun Pharmaceutical Industries | Jerry St. Peter, VP & Head, Ophthalmic Business
TearLab | Seph Jensen, CEO
TearScience | Joe Boorady, CEO
Panel Discussion
Moderated By:
Edward Holland, MD, Director, Cornea Services - Cincinnati Eye Institute
Participants:
Alice Epitropoulos, MD - Ophthalmic Surgeons & Consultants of Ohio
Sam Garg, MD, Vice Chair, Clinical Ophthalmology & Medical Director - Gavin Herbert Eye Institute
Terry Kim, MD, Professor of Ophthalmology - Duke University Eye Center
Stephen Lane, MD - Associated Eye Care
2:15 - 2:55 PM
“Making Myopia Great Again”: New Opportunities in Low Myopia
Market Overview
Gilbert H. Kliman, MD, Managing Director - InterWest Partners
Michael Lachman, President - EyeQ Research
Stephen Slade, MD, Surgeon - Slade & Baker Vision Center
Panel Discussion
Co-Moderated By:
Gilbert H. Kliman, MD, Managing Director - InterWest Partners
Stephen Slade, MD, Surgeon - Slade & Baker Vision Center
PRK | Laurent Attias, SVP, Head of Strategy, BD&L and M&A - Alcon
LASIK | Terence Koritz, VP, Global Strategic Marketing, Surgical - Johnson & Johnson Vision
PiXL | Rajesh Rajpal, MD, CMO - Avedro
SMILE | Steve Schallhorn, MD, CMO - Carl Zeiss Meditec
Contact Lenses | Cal Roberts, MD, SVP & Chief Medical Officer - Bausch + Lomb
2:55 - 3:25 PM
Afternoon Networking & Refreshment Break
Sponsored By:
3:25 - 4:05 PM
Role of the Mega-Practice/ Private Equity Partnership in the Future of Innovative Eyecare Delivery
Market Overview
Bruce Maller, President & CEO - BSM Consulting
Panel Discussion
Moderated By:
Richard Lindstrom, MD, Founder & Attending Surgeon - Minnesota Eye Consultants
Participants:
David Alpern, Partner - Varsity Healthcare Partners
Chris Graber, Principal - Waud Capital Partners
Brett Katzen, MD, President - Katzen Eye Group
Bruce Maller, President & CEO - BSM Consulting
Brent Wilde, President - Minnesota Eye Consultants
4:05 - 4:55 PM
Masters of the Industry
Moderated By:
William J. Link, PhD, Managing Director - Versant Ventures
Participants:
Michael Ball, CEO - Alcon
Thomas Burns, President & CEO - Glaukos
Tom Frinzi, Worldwide President, Surgical - Johnson & Johnson Vision
Ludwin Monz, PhD, President & CEO - Carl Zeiss Meditec AG
Joseph Papa, CEO - Valeant Pharmaceuticals
Perry Sternberg, Head, US Commercial - Shire
4:55 - 5:00 PM
Closing Remarks
William J. Link, PhD, Managing Director - Versant Ventures
5:00 - 6:00 PM
Networking Reception
Sponsored By:
